Cargando…
Effects of single versus dual antiplatelet therapy on the adverse events after transcatheter aortic valve implantation: A meta‐analysis
Dual antiplatelet therapy (DAPT) was currently recommended for transcatheter aortic valve implantation (TAVI) postoperative management in clinical application. However, POPular‐TAVI trial showed DAPT increased the incidence of adverse events compared to single antiplatelet therapy (SAPT). Herein, we...
Autores principales: | Yu, Shengqin, Zhang, Shuying, Yao, Changli, Liu, Jihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715399/ https://www.ncbi.nlm.nih.gov/pubmed/34664716 http://dx.doi.org/10.1002/clc.23731 |
Ejemplares similares
-
Procedural outcomes in patients with dual versus single antiplatelet therapy prior to transcatheter aortic valve replacement
por: Seoudy, Hatim, et al.
Publicado: (2021) -
Association Between Sarcopenia and Adverse Events Following Transcatheter Aortic Valve Implantation
por: Brown, Andrew D., et al.
Publicado: (2021) -
Single Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials
por: Ahmad, Yousif, et al.
Publicado: (2022) -
Dual Antiplatelet Therapy vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis
por: Zhang, Yipeng, et al.
Publicado: (2021) -
Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient‐Level Meta‐Analysis
por: Brouwer, Jorn, et al.
Publicado: (2021)